Non-insulin injected drug(s)-Byetta, (Exenatide) Posts on Medivizor
Navigation Menu

Non-insulin injected drug(s)-Byetta, (Exenatide) Posts on Medivizor

Evaluating GLP-1 medications and heart health in patients with type 2 diabetes

Evaluating GLP-1 medications and heart health in patients with type 2 diabetes

Posted by on Jun 14, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study looked at how medications similar to the GLP-1 hormone affect heart health for patients with type 2 diabetes (T2D). It found that GLP-1-like medications did not significantly improve heart health, but reduced overall mortality. Some background T2D is a disorder in which the body does not respond well to the hormone insulin....

Read More

The cost effectiveness of semaglutide compared to exenatide and dulaglutide in type 2 diabetes

Posted by on Apr 12, 2019 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to compare the cost-effectiveness of semaglutide (Ozempic) to extended-release (ER) exenatide (Byetta, Bydureon) and dulaglutide (Trulicity) ?in the treatment of type 2 diabetes (T2D). The main finding of the study was that once-weekly semaglutide was more cost-effective than exenatide and...

Read More

Effect of long-acting exenatide on blood sugar, body weight and blood vessels in type 2 diabetes

Effect of long-acting exenatide on blood sugar, body weight and blood vessels in type 2 diabetes

Posted by on Feb 28, 2019 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to examine the effect of long-acting exenatide on blood sugar control, body weight and the thickness of the wall of the carotid artery in patients with type 2 diabetes (T2D). The main finding of the study was that this treatment improved all these parameters in patients with T2D. Some background Patients withT2D...

Read More